t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia

Am J Hematol. 2015 Nov;90(11):E211-2. doi: 10.1002/ajh.24143. Epub 2015 Oct 12.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Chromosomes, Human, Pair 16
  • Chromosomes, Human, Pair 22
  • Chromosomes, Human, Pair 9
  • Core Binding Factors / genetics*
  • Fusion Proteins, bcr-abl / genetics*
  • Gene Expression
  • Humans
  • Karyotyping
  • Leukemia, Myeloid, Acute / diagnosis*
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / pathology
  • Male
  • Oncogene Proteins, Fusion / genetics*
  • Translocation, Genetic*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • BCR-ABL1 fusion protein, human
  • CBFbeta-MYH11 fusion protein
  • Core Binding Factors
  • Oncogene Proteins, Fusion
  • Fusion Proteins, bcr-abl